Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children [NA]

View source ↗

Summary

A pediatric Crohn's disease trial is evaluating the combination of infliximab with azathioprine; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azathioprine (azathioprine)
  • Infliximab (infliximab)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Crohn's Diseases, Crohn's Disease in Pediatric Patient | NA | Status: NOT_YET_RECRUITING